Publications by authors named "A Galan de Mera"

Article Synopsis
  • The study evaluated the malignancy risk linked to ixekizumab in patients with rheumatological conditions through a systematic review of randomized controlled trials (RCTs) and long-term extension studies (LTEs).
  • Meta-analyses indicated a low overall risk of malignancy, with Peto odds ratios showing varied results when compared to placebo and another drug, adalimumab.
  • The research concluded that while ixekizumab generally poses a low risk for malignancy, certain conditions, like nonmelanoma skin cancer, may be exceptions for patients with psoriatic arthritis and axial spondyloarthritis.
View Article and Find Full Text PDF

Concerns about the increasing consumption of medicines have been raised due to their contribution to waste pollution and environmental impacts. However, limited research addresses the profile and disposal practices of household medicines, particularly in Latin America. Therefore, this study analyzes the consumption, waste, and disposal of medicines within households in the commune of La Serena, Chile.

View Article and Find Full Text PDF

Background: People with HIV have a substantially higher risk of anal cancer than the general population. We aimed to identify risk factors associated with the development of anal cancer among people with HIV to implement more effective and targeted screening strategies.

Methods: We conducted a multicentre retrospective cohort study in 16 hospitals across Catalonia and the Balearic Islands, Spain, between Jan 1, 1998, and Dec 31, 2022.

View Article and Find Full Text PDF

Aims: Over 50% of breast cancer cases are "Human epidermal growth factor receptor 2 (HER2) low breast cancer (BC)", characterized by HER2 immunohistochemistry (IHC) scores of 1+ or 2+ alongside no amplification on fluorescence in situ hybridization (FISH) testing. The development of new anti-HER2 antibody-drug conjugates (ADCs) for treating HER2-low breast cancers illustrates the importance of accurately assessing HER2 status, particularly HER2-low breast cancer. In this study we evaluated the performance of a deep-learning (DL) model for the assessment of HER2, including an assessment of the causes of discordances of HER2-Null between a pathologist and the DL model.

View Article and Find Full Text PDF

Adipokines are a heterogeneous group of signalling molecules secreted prevalently by adipose tissue. Initially considered as regulators of energy metabolism and appetite, adipokines have been recognized for their substantial involvement in musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, and many others. Understanding the role of adipokines in rheumatic inflammatory and autoimmune diseases, as well as in other musculoskeletal diseases such as intervertebral disc degeneration, is crucial for the development of novel therapeutic strategies.

View Article and Find Full Text PDF